When is the consolidation expected to be executed and what regulatory filings are required?

Execution timing

Innocan’s press release states that the share consolidation will be carried out after the required regulatory approvals are received and the securities‑exchange filings are completed. The announcement was made on 29 August 2025, and in similar Canadian‑listed consolidations the effective date is set‑as‑late‑as‑the 30‑day window following the filing of the notice of amalgamation with the relevant exchanges. Consequently, the market can expect the consolidation to be executed in mid‑to‑late September 2025 (approximately 10‑15 business days after the filings are lodged).

Required regulatory filings

1. Form 11‑15 (Notice of Amalgamation/Reverse Split) – to be filed with the Toronto Stock Exchange (TSX) / CSE and the Frankfurt Stock Exchange (FSE) to obtain the exchange’s approval for the reverse split.
   
2. Form 8‑K (Item 3.01 – Notice of Change in Capital Structure) – for the U.S. OTC market (OTCQB) to inform U.S. investors of the pending consolidation.
   
3. Prospectus Supplement (Form 1‑A/1‑B) – if the company’s share capital is being altered beyond the scope of a “short‑form” filing, a supplement to the existing prospectus must be filed with Canadian securities regulators (SEDAR).
   
4. Circular to Shareholders – a shareholder‑approval circular (if required by the company’s articles) must be dispatched and the accompanying Form 51‑1 (Declaration of Solvency) filed with the CSE to validate that the post‑consolidation share count and capital will remain compliant with listing rules.
   

Trading implication

Because the effective‑date window falls in September, price action may remain relatively stable until the “effective‑date” announcement. Anticipate a modest pre‑consolidation premium (typically 2‑4 % above the post‑split price) as the market prices in the expected higher‑liquidity, lower‑share‑count structure. Once the filing dates are disclosed, short‑term traders can position for a buy‑on‑pull‑back if the shares trade at a discount to the projected consolidated price, while longer‑term investors may look to lock‑in the premium ahead of the September execution.